Technology

Where Advanced Science Meets AI-Powered Precision

At 1Cell.Ai, technology is at the core of how we redefine cancer diagnostics. Our platform merges cutting-edge innovations in molecular science, single cell analysis, bioinformatics, and artificial intelligence—delivering real-time, actionable insights to clinicians, researchers, and biopharma and pharma partners worldwide.

Core Technology Pillars

AI-Driven Insights

Machine learning models optimized for real-time molecular interpretation.

Single Cell Multi-Omics

True single-cell resolution across genomics, transcriptomics, and proteomics.

Integrated Bioinformatics

Dynamic multi-omics data processing and interpretation at scale.

Scalable Precision Platform

Built to support research, diagnostics, and clinical deployment worldwide.

AI-Powered Precision Oncology

We leverage advanced machine learning and AI algorithms designed specifically for oncology. Our AI models analyze complex genomic, transcriptomic, and proteomic data, providing:

By integrating AI at every step, we enable faster, more accurate decision-making in precision oncology.

Real-time molecular insights for treatment selection

Predictive analytics to assess therapy response and resistance

Pattern recognition across large-scale clinical datasets

Automated, scalable interpretation of multi-omics biomarkers

Technology at Work: AI Meets Multi-omics

Redefining the Future of Cancer Care OneCell Ai’s technology is driving a new standard in oncology, drug development, and precision medicine. By unlocking cell-level intelligence with AI, we empower healthcare professionals with the tools needed to make smarter, faster, and more personalized treatment decisions.

Next-Generation Sequencing (NGS)

High-throughput genomic analysis.

Machine Learning & Bioinformatics

AI models trained on diverse oncology datasets.

Data-Driven Biomarker Discovery

Multiomics insights for precision treatment planning.

Collaboration

Cross-functional platforms connecting clinicians and oncologists, researchers and labs pharma and bio-pharma partners

The Evolution of Cancer Diagnostics

Three generations of biopsy innovation, transforming how cancer is detected, monitored, and treated.

Gen 1

Tissue Biopsy

Foundation of Precision Oncology

Gold standard
Direct tissue sampling
Histological & molecular profiling
Multi-omic data (static)

Gen 2

Liquid Biopsy

Convenience and Accessibility

Non-invasive blood draw
Longitudinal monitoring
Tumor burden quantification
Real-time insights

Gen 3

Cell Biopsy

Single Cell Precision

Captures live CTCs from blood
True single cell resolution
Reveals tumor complexity & evolution
Multi-omic data (dynamic)

Built for Precision, Backed by Science

Single Cell Genomics

Understanding Cancer at Its Core

Traditional bulk sequencing often overlooks key variations. Our platform uses true single-cell resolution to analyze individual tumor cells—unlocking powerful insights into:

Tumor heterogeneity
Rare mutations and subclonal populations
Real-time monitoring of tumor evolution
Guidance for personalized, adaptive therapy strategies

Bioinformatics & Data Science

Making Complex Data Clinically Actionable

Our bioinformatics engine bridges the gap between raw data and clinical insight. Key capabilities include:

Multi-omics data integration across modalities
Advanced visualization and modeling tools
Custom AI algorithm development
Scalable infrastructure for clinical trials, research and diagnostics

Platform Advantages

Designed for Flexibility, Built for Impact

Our technology platform is optimized for clinical environments, research workflows, and real-world implementation:

Non-Invasive & Real-Time
Liquid biopsy and single-cell workflows reduce need for surgical procedures
Clinically Validated
Rigorous internal validation and regulatory compliance
Scalable & Modular
Adaptable across labs, trials, and care systems
Tailored for Oncology
Purpose-built for the complexities of cancer care

Leading the Future of Cell Science and Data Innovation

At OneCell Ai, we are committed to staying at the forefront of cell science and data science innovations. Our comprehensive genomic solutions integrate Next-Generation Sequencing (NGS) with advanced bioinformatics, AI, machine learning, and data analytics to uncover multi-omics biomarkers for improved cancer management. Every genomic result is meticulously reviewed by our scientific board, ensuring that quality-driven insights lead to personalized and effective treatment decisions. Backed by state-of-the-art laboratory equipment and computational tools, we empower clinicians to make informed choices with precision and confidence.